Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
176517-01-4----[1] 77 💬
281409-90-7----[1] 77 💬
3[14C]-ONO-5788----[1] 77 💬
4[CAM2029 ]----[1] 77 💬
5[CAM2029]----[1] 77 💬
6[CRN00808]----[1] 77 💬
7[ISIS 766720]----[1] 77 💬
8Acetaminophen[1] Acetaminophen[1] Acetaminophen 💬 [2] PTGS1,
PTGS2 💬 		[23] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[19] 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
9Acetate[1] Acetate---[52] 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
10Acetato de octreótida----[1] 77 💬
11Adipose Tissue Biopsy----[1] 77 💬
12Alesse----[1] 77 💬
13ALXN2420----[1] 77 💬
14ATL1103----[1] 77 💬
15AVANDIA*28CPR RIV 4MG----[1] 77 💬
16Behavioral: Home administration----[1] 77 💬
17BIM 23A760----[1] 77 💬
18BIM23A760----[1] 77 💬
19BIM23B065----[1] 77 💬
20Blood sample----[33] 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
21Blood tests: IGF-1, AST/ALT/ALP/TBIL, GTT----[1] 77 💬
22C2L-OCT-01 PR----[1] 77 💬
23C2L-OCT-01 PR , 10mg----[1] 77 💬
24C2L-OCT-01 PR , 20mg----[1] 77 💬
25C2L-OCT-01 PR , 30mg----[1] 77 💬
26C2L-OCT-01 PR 30 mg----[1] 77 💬
27C2L-OCT-01 PR, 10 or 20 mg----[1] 77 💬
28C2L-OCT-01 PR, 20 mg----[1] 77 💬
29C2L-OCT-01 PR, 30 mg----[1] 77 💬
30Cabaser----[2] 6, 77 💬
31Cabergolin----[2] 74, 77 💬
32Cabergoline[1] Cabergoline[1] Cabergoline 💬 [2] DRD2,
PRL 💬 		[14] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[4] 6, 74, 75, 77 💬
33CAM2029----[1] 77 💬
34CAM2029 (Octreotide subcutaneous depot)[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
35CAM2029 (Octreotide subcutaneous depot) _prefilled syringe_prefilled syringe[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
36CAM2029 (Octreotide subcutaneous depot)_ prefilled pen[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
37CAM2029 (Octreotide subcutaneous depot)_ prefilled syringe[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
38CAM2029 (Octreotide subcutaneous depot)_pre-filled pen[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
39CAM2029 (Octreotide subcutaneous depot)_pre-filled syringe[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
40CAM2029 (Octreotide subcutaneous depot)_prefilled pen[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
41CAM2029 (Octreotide subcutaneous depot)_prefilled syringe[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
42CAM2029-BR----[1] 77 💬
43CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE----[2] 75, 77 💬
44Clomiphene citrate----[2] 74, 77 💬
45CMRI----[1] 77 💬
46Combination with dopamine agonist cabergoline[2] Cabergoline,
Dopamine		[3] Dopamine hydrochloride ,
Cabergoline ,
Dopamine 💬 		[6] DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
PRL 💬 		[17] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 77 💬
47Combination with somatostatin analogue octreotide[2] Octreotide,
Somatostatin		[6] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Somatostatin ,
Octreotide hydrochloride 💬 		[5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
48CRN00808----[1] 77 💬
49CRN00808 - is an oral non-peptide small molecule somatostatin receptor 2 (SST2)[1] Somatostatin[1] Somatostatin 💬 [5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
50CRN00808 is an oral non-peptide small molecule somatostatin receptor 2 (SST2) agonist[1] Somatostatin[1] Somatostatin 💬 [5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
51CRN00808 è un agonista del recettore 2 della somatostatina (SST2), orale, non peptidico a piccole dimensioni molecolari[1] Somatostatin[1] Somatostatin 💬 [5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
52CRN00808.HCl----[1] 77 💬
53Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly pamoate----[1] 77 💬
54Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Ly pamoate----[1] 77 💬
55Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys pamoate----[1] 77 💬
56Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) pamoate----[1] 77 💬
57Cyclo(diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe)----[2] 75, 77 💬
58D-Phenylalanyl-L-h----[1] 77 💬
59D-Phenylalanyl-L-he----[1] 77 💬
60D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-trypto----[1] 77 💬
61D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophan[2] D-Tryptophan,
Tryptophan		[1] Tryptophan 💬 --[1] 77 💬
62D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-hemiscystyl-L-threonino----[1] 77 💬
63D-Tryptophan[2] D-Tryptophan,
Tryptophan		[1] Tryptophan 💬 --[1] 77 💬
64Debio 4126----[1] 77 💬
65Denosumab[1] Denosumab[1] Denosumab 💬 [1] TNFSF11 💬 [8] Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬[11] 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬
66DG3173----[1] 77 💬
67Diagnostic Test: Oral Glucose Tolerance Test----[6] 6, 13, 57, 65, 77, 299 💬
68Diagnostic Test: Radiological tests----[1] 77 💬
69Diagnostic Test: Subcutaneous administration of recombinant human IGF-1----[1] 77 💬
70Diagnostic Test: Total body magnetic resonance imaging----[1] 77 💬
71Direct surgery for acromegaly----[1] 77 💬
72Dopamine[1] Dopamine[2] Dopamine hydrochloride ,
Dopamine 💬 		[5] DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		[13] Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬[5] 6, 7, 17, 74, 77 💬
73Dopastatin[1] Dopastatin---[1] 77 💬
74DOSTINEX----[2] 75, 77 💬
75Dostinex 0,5 mg Tabletten----[1] 77 💬
76Dostinex 0.5mg tabletts----[1] 77 💬
77DOSTINEX 2CPR 0,5MG----[1] 77 💬
78Empagliflozin[1] Empagliflozin[1] Empagliflozin 💬 --[17] 28, 46, 57, 58, 65, 67, 72, 77, 86, 96, 97, 113, 222, 223, 257, 298, 299 💬
79Escitalopram[1] Escitalopram[2] Escitalopram oxalate ,
Escitalopram 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[5] 2, 6, 13, 46, 77 💬
80Escitalopram 10 mg[1] Escitalopram[2] Escitalopram oxalate ,
Escitalopram 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 77 💬
81Escitalopram Hexal 10 mg[1] Escitalopram[2] Escitalopram oxalate ,
Escitalopram 💬 		[1] SLC6A4 💬 [3] Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬[1] 77 💬
82Evista 60mg film-coated tablets----[1] 77 💬
83Furosemide[1] Furosemide[1] Furosemide 💬 [1] SLC12A2 💬 [3] Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬[5] 6, 57, 77, 86, 222 💬
84Gadolinium[1] Gadolinium---[8] 13, 34, 46, 65, 77, 86, 113, 305 💬
85Genotropin----[6] 13, 77, 107, 187, 193, 222 💬
86GHR-LRX----[1] 77 💬
87Gold[1] Gold---[71] 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
88Growth Hormone Receptor Antagonist----[1] 77 💬
89H01C B03----[1] 77 💬
90Implante de Octreótida----[1] 77 💬
91Injectable Somatostatin Analogs (octreotide or lanreotide)[3] Lanreotide,
Octreotide,
Somatostatin		[7] Octreotide ,
Octreotide acetate ,
Lanreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Somatostatin ,
Octreotide hydrochloride 💬 		[5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
92Insulin----[6] 6, 13, 46, 75, 77, 299 💬
93IONIS GHR-LRx----[1] 77 💬
94IONIS-GHR-LRx----[1] 77 💬
95IPSTYL----[1] 77 💬
96IPSTYL - 60 MG SOLUZIONE INIETTABILE PER USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA----[1] 77 💬
97IPSTYL - 90 MG SOLUZIONE INIETTABILE PER USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA----[1] 77 💬
98Ipstyl 120 mg----[1] 77 💬
99Ipstyl 90 mg----[1] 77 💬
100Ipstyl Autogel----[1] 77 💬
101ISIS 766720----[1] 77 💬
102It is a chimera of a Dopamin 2 and an Somatostatin 2 receptor agonist[1] Somatostatin[1] Somatostatin 💬 [5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
103ITF2984----[1] 77 💬
104ITF2984 1000 mcg----[1] 77 💬
105ITF2984 2000 mcg----[1] 77 💬
106ITF2984 500 mcg----[1] 77 💬
107ITF2984 diacetate----[1] 77 💬
108Ketogenic Diet----[7] 13, 21, 49, 77, 127, 145, 148 💬
109LANREOTIDA----[1] 77 💬
110Lanreotida Autogel 120 mg----[1] 77 💬
111Lanreotide[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[5] 67, 73, 77, 85, 298 💬
112Lanreotide (Autogel formulation)[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
113Lanreotide (Autogel formulation), duration of treatment 24-56 weeks, depending on dose interval[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
114Lanreotide (Autogel formulation), duration of treatment 46-48 weeks[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
115Lanreotide 60Mg Solution for Injection[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
116LANREOTIDE ACETATE[2] Acetate,
Lanreotide		[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[4] 67, 77, 85, 298 💬
117LANREOTIDE ACETATO[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
118Lanreotide ATG[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
119Lanreotide ATG 120mg[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
120Lanreotide autogel[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
121Lanreotide Autogel 120 mg[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
122Lanreotide Autogel 120mg[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
123Lanreotide Autogel and Octreotide LAR[2] Lanreotide,
Octreotide		[6] Octreotide ,
Octreotide acetate ,
Lanreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
124Lanreotide Autogel®[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
125Lanreotide PRF[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
126Lanreotide-Autogel 120 mg[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
127Liraglutide[1] Liraglutide[1] Liraglutide 💬 [1] GLP1R 💬 [4] Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[5] 6, 13, 75, 77, 193 💬
128MAR002----[1] 77 💬
129Medical History, demographics----[1] 77 💬
130Medications for acromegaly----[1] 77 💬
131Mediterranean Diet----[4] 13, 77, 97, 265 💬
132Metformin[1] Metformin[2] Metformin hydrochloride ,
Metformin 💬 		[2] PRKAA1,
PRKAA2 💬 		[20] AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬[31] 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
133MRI----[6] 13, 48, 70, 77, 85, 278 💬
134Mycapssa----[1] 77 💬
135Mycapssa?----[1] 77 💬
136Mycapssa®----[1] 77 💬
137Mycapssa™----[1] 77 💬
138Octreolin----[1] 77 💬
139Octreotid----[1] 77 💬
140OCTREOTIDA[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
141OCTREOTIDA ACETATO[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
142Octreotidacetat----[1] 77 💬
143Octreotide[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[8] 67, 75, 77, 84, 85, 89, 193, 227 💬
144OCTREOTIDE ACETATE[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 77, 227 💬
145Octreotide acetate 30 mg suspension[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
146Octreotide acetate and cabergoline/Octrotide and Somavert[3] Acetate,
Cabergoline,
Octreotide		[6] Octreotide ,
Cabergoline ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[3] DRD2,
PRL,
SSTR2 💬 		[16] Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬[1] 77 💬
147Octreotide acetate LAR[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
148Octreotide Acetate Microspheres for Injection injection[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
149Octreotide acetate prolonged release, 30 mg[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
150OCTREOTIDE ACETATO[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 77, 227 💬
151Octreotide capsules[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
152Octreotide FluidCrystal® injection depot[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
153OCTREOTIDE HYDROCHLORIDE[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
154Octreotide Implant[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
155Octreotide LAR[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 67, 77, 227 💬
156Octreotide LAR 30 MG Injection[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
157Octreotide LAR 30mg[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
158Octreotide subcutaneous depot[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
159Octreotide-LAR[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 67, 77 💬
160Octreotide-LAR or lanreotide[2] Lanreotide,
Octreotide		[6] Octreotide ,
Octreotide acetate ,
Lanreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
161OGTT----[1] 77 💬
162ONO-5788----[1] 77 💬
163Other: 1H/31P Magnetic Resonance Spectroscopy----[1] 77 💬
164Other: Blood draw----[17] 2, 6, 11, 13, 18, 39, 46, 57, 77, 84, 85, 86, 88, 96, 97, 167, 299 💬
165Other: MRI, dual-energy, x-ray absorptiometry, muscle ultrasounds, blood testing----[2] 75, 77 💬
166Other: Oral Glucose Tolerance Test (OGTT)----[1] 77 💬
167Other: oral glucose tolerance testing----[1] 77 💬
168Other: Performed 2 diagnostic tests (2 OGTT tests with 75g of Glucose)----[1] 77 💬
169Other: Questionnaires----[8] 3, 6, 13, 41, 46, 77, 96, 226 💬
170Other: Thyroid sonography----[1] 77 💬
171Paltusotine[1] Paltusotine[2] Paltusotine ,
Paltusotine hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
172Paltusotine (Free base)[1] Paltusotine[2] Paltusotine ,
Paltusotine hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
173PaltusotineProduct Code: CRN00808Pharmaceutical Form: TabletINN or Proposed INN: Paltusotine (Free base)CAS Number: 2172870-89-0Current Sponsor code: CRN00808Other descriptive name: PaltusotineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 20-Pharmaceutical form of the placebo: TabletRoute of administration of the placebo: Oral use[1] Paltusotine[2] Paltusotine ,
Paltusotine hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
174Pasireotida----[2] 75, 77 💬
175Pasireotide[1] Pasireotide[3] Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[4] 67, 74, 75, 77 💬
176Pasireotide (SOM230), Octreotide (Sandostatin)[2] Octreotide,
Pasireotide		[8] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate ,
Octreotide hydrochloride 💬 		[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
177Pasireotide 20mg[1] Pasireotide[3] Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 75, 77 💬
178Pasireotide 40mg[1] Pasireotide[3] Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 75, 77 💬
179Pasireotide 60mg[1] Pasireotide[3] Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 75, 77 💬
180PASIREOTIDE DIASPARTATE[1] Pasireotide[3] Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 75, 77 💬
181Pasireotide LAR[1] Pasireotide[3] Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 67, 75, 77 💬
182Pasireotide LAR 60 mg[1] Pasireotide[3] Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
183Pasireotide long acting release formulation[1] Pasireotide[3] Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
184PASIREOTIDE PAMOATE[1] Pasireotide[3] Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 75, 77 💬
185Pasireotide s.c.[1] Pasireotide[3] Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		[4] SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 75, 77 💬
186PEGVISOMANT[1] Pegvisomant[1] Pegvisomant 💬 [1] GHR 💬 [6] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[2] 77, 265 💬
187Pegvisomant (somavert)[1] Pegvisomant[1] Pegvisomant 💬 [1] GHR 💬 [6] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 77 💬
188Pegvisomant treatment[1] Pegvisomant[1] Pegvisomant 💬 [1] GHR 💬 [6] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 77 💬
189Pegvisomant/ Sandostatin LAR[1] Pegvisomant[1] Pegvisomant 💬 [1] GHR 💬 [6] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 77 💬
190PN-800467----[1] 77 💬
191Pre-treatment with octreotide[1] Octreotide[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
192Preoperative lanreotide treatment[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
193Radiation: Gamma knife radiosurgery----[1] 77 💬
194Radiation: radiotherapy----[1] 77 💬
195Raloxifene[1] Raloxifene[2] Raloxifene hydrochloride ,
Raloxifene 💬 		[2] ESR1,
ESR2 💬 		[10] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[2] 46, 77 💬
196Recombinant human growth hormone----[4] 77, 193, 265, 276 💬
197Rosiglitazone[1] Rosiglitazone[2] Rosiglitazone maleate ,
Rosiglitazone 💬 		[1] PPARG 💬 [12] AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬[7] 46, 57, 75, 77, 97, 222, 265 💬
198Saline----[12] 2, 6, 13, 17, 18, 53, 67, 77, 86, 97, 168, 299 💬
199Sandostatin----[1] 77 💬
200Sandostatin (Octreotide Acetate)[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
201Sandostatin LAR----[5] 67, 77, 84, 193, 227 💬
202SANDOSTATIN LAR 10 mg polvo para suspensión inyectable----[1] 77 💬
203Sandostatin LAR 10mg----[1] 77 💬
204SANDOSTATIN LAR 20 mg polvo para suspensión inyectable----[1] 77 💬
205Sandostatin LAR 20mg----[1] 77 💬
206Sandostatin LAR 20mg, 30mg----[1] 77 💬
207SANDOSTATIN LAR 30 mg polvo para suspensión inyectable----[1] 77 💬
208Sandostatin LAR 30mg----[1] 77 💬
209Sandostatin LAR Depot----[1] 77 💬
210Sandostatin LAR Depot versus transsphenoidal surgery----[1] 77 💬
211Sandostatin LAR Injection, 10mg, 20mg, 30mg----[1] 77 💬
212Sandostatin LAR Monatsdepot 20 mg----[1] 77 💬
213Sandostatin LAR ®----[1] 77 💬
214Sandostatin LAR ® (octreotide acetate LAR) 30 MG[2] Acetate,
Octreotide		[5] Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		[1] SSTR2 💬 [5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
215Sandostatin LAR, 10 mg, 20 mg and 30 mg----[1] 77 💬
216Sandostatin LAR-Monatsdepot----[1] 77 💬
217Sandostatin LAR-Monatsdepot 10 mg----[1] 77 💬
218Sandostatin LAR-Monatsdepot 20 mg----[1] 77 💬
219Sandostatin LAR-Monatsdepot 30 mg----[1] 77 💬
220Sandostatin LAR®----[1] 77 💬
221Sandostatin ® injection----[1] 77 💬
222Sandostatina----[2] 67, 77 💬
223SANDOSTATINA - LAR 10 MG/2 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE 1 FLACONE + 2 FIALE DA 2 ML + SET DA INIEZIONE----[1] 77 💬
224SANDOSTATINA - LAR 10 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI----[1] 77 💬
225SANDOSTATINA - LAR 20 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI----[2] 67, 77 💬
226SANDOSTATINA - LAR 30 MG/2 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE 1 FLACONE + 2 FIALE DA 2 ML + SET DA INIEZIONE----[1] 77 💬
227SANDOSTATINA - LAR 30 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI----[1] 77 💬
228SANDOSTATINA LAR----[2] 67, 77 💬
229SANDOSTATINA LAR IM FL 20MG 2F----[1] 77 💬
230Sandostatine L.P. 10 mg, poudre et solvant en seringue préremplie pour suspension injectable (IM)----[1] 77 💬
231Sandostatine L.P. 20 mg, poudre et solvant en seringue préremplie pour suspension injectable (IM)----[1] 77 💬
232Sandostatine L.P. 30 mg, poudre et solvant en seringue----[1] 77 💬
233Sandostatine L.P. 30 mg, poudre et solvant pour suspension injectable à libération prolongée----[1] 77 💬
234Sandostatine LAR 20 mg----[1] 77 💬
235Sandostatine Long Acting Repeatable 30 mg----[1] 77 💬
236Sandostatin® LAR----[1] 77 💬
237Sandostatin® LAR®-Monatsdepot 10 mg----[1] 77 💬
238Sandostatin® LAR®-Monatsdepot 20 mg----[1] 77 💬
239Sandostatin® LAR®-Monatsdepot 30 mg----[1] 77 💬
240Sign and symptoms: questionnaire----[1] 77 💬
241SIGNIFOR----[2] 75, 77 💬
242Sitagliptin[1] Sitagliptin[3] Sitagliptin phosphate ,
Sitagliptin ,
Sitagliptin phosphate 💬 		[1] DPP4 💬 [2] Protein digestion and absorption, Virion - Hepatitis viruses 💬[6] 6, 63, 75, 77, 233, 299 💬
243SMS995----[1] 77 💬
244SMS995B----[1] 77 💬
245SOM022----[1] 77 💬
246SOM230----[3] 74, 75, 77 💬
247SOM230 LAR----[2] 75, 77 💬
248SOM230 LAR, 20 mg----[2] 75, 77 💬
249SOM230, 300micrograms----[2] 75, 77 💬
250SOM230, 600 micrograms----[2] 75, 77 💬
251SOM230, 900 micrograms----[2] 75, 77 💬
252SOM230B----[2] 75, 77 💬
253SOM230C----[1] 77 💬
254Somatostatin[1] Somatostatin[1] Somatostatin 💬 [5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 67, 77 💬
255Somatostatin analog (lanreotide or octreotide)[3] Lanreotide,
Octreotide,
Somatostatin		[7] Octreotide ,
Octreotide acetate ,
Lanreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Somatostatin ,
Octreotide hydrochloride 💬 		[5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
256Somatostatin Receptor Ligand (SRL)[1] Somatostatin[1] Somatostatin 💬 [5] SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
257SOMATULINA AUTOGEL----[1] 77 💬
258Somatuline ATG----[1] 77 💬
259Somatuline Autogel----[2] 67, 77 💬
260Somatuline Autogel (lanreotide acetate)[2] Acetate,
Lanreotide		[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
261Somatuline Autogel 120----[1] 77 💬
262SOMATULINE AUTOGEL 120 mg----[1] 77 💬
263Somatuline Autogel 120mg----[1] 77 💬
264Somatuline Autogel 60mg----[1] 77 💬
265Somatuline Autogel 90mg----[1] 77 💬
266Somatuline Autogel Injectable 120----[1] 77 💬
267Somatuline Autogel® (lanreotide) 60, 90, 120 mg.[1] Lanreotide[1] Lanreotide acetate 💬 [2] SSTR2,
SSTR5 💬 		[5] Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 77 💬
268Somatuline Autogel® 60, 90 or 120 mg----[1] 77 💬
269SOMATULINE L.P. 120 mg, solution injectable à libération prolongée en seringue préremplie----[1] 77 💬
270Somatuline LP 120mg----[1] 77 💬
271SOMATULINE® AUTOGEL® 120 mg solution for injection----[1] 77 💬
272SOMAVERT----[1] 77 💬
273Somavert (Pegvisomant)[1] Pegvisomant[1] Pegvisomant 💬 [1] GHR 💬 [6] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[1] 77 💬
274Somavert 10 mg----[1] 77 💬
275SOMAVERT 15 mg----[1] 77 💬
276SOMAVERT 20 mg----[1] 77 💬
277Surgery for acromegaly----[1] 77 💬
278SYHX2008----[1] 77 💬
279SYHX2008 injection----[1] 77 💬
280Tadalafil[1] Tadalafil[1] Tadalafil 💬 [1] PDE5A 💬 [2] Purine metabolism, cGMP-PKG signaling pathway 💬[8] 6, 51, 75, 77, 84, 86, 113, 210 💬
281TE-8214 - SAD----[1] 77 💬
282Transcranial Magnetic Stimulation----[2] 13, 77 💬
283Transnasal butterfly surgery----[1] 77 💬
284Transsphenoidal adenomectomy----[1] 77 💬
285Transsphenoidal surgery----[1] 77 💬
286Tryptophan[1] Tryptophan[1] Tryptophan 💬 --[3] 6, 46, 77 💬
287UnK----[1] 77 💬
288Zoledronic acid[1] Zoledronic acid[5] Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		[1] FDPS 💬 [3] Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬[16] 5, 6, 13, 17, 46, 75, 77, 93, 95, 96, 97, 270, 274, 282, 299, 333 💬